HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOVENT BIO

79.650

0.000

Volume:239.97K

Turnover:18.93M

Market Cap:131.66B

PE:-1.25K

High:79.750

Open:79.000

Low:78.850

Close:79.300

Loading ...

Overview Company News Filings

Innovent and HUTCHMED Jointly Announce That the Frusica-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China

THOMSON REUTERS

Innovent Biologics' NDA for Thyroid Eye Disease Drug Gets China Nod

MT Newswires Live

Innovent Biologics - Igf-1R Monoclonal Antibody Sycume Received Approval by Nmpa for Thyroid Eye Disease

THOMSON REUTERS

BRIEF-Innovent Is Said To Consider Licensing Partnership For Cancer Drug- Bloomberg News

Innovent Is Said to Consider Licensing Partnership for Cancer Drug- Bloomberg News

THOMSON REUTERS

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of Ibi363 (Pd-1/Il-2Α-Bias Bispecific Antibody Fusion Protein) in Melanoma

THOMSON REUTERS

Innovent Biologics Anti-Cancer Drug's NDA Accepted by China's NMPA; Shares Slide 3%

MT Newswires Live

BRIEF-Innovent Biologics Says NMPA China Accepts New Drug Application For Ipilimumab Injection

Nmpa Accepts Nda and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic Ctla-4 Inhibitor, in Combination With Sintilimab as Neoadjuvant Treatment for Colon Cancer

THOMSON REUTERS

Innovent Biologics - Nmpa China Accepts New Drug Application & Grants Priority Review Designation to Ipilimumab Injection

THOMSON REUTERS

Nomura Adjusts Innovent Biologics' Price Target to HK$54.60 From HK$58.09, Keeps at Buy

MT Newswires Live

Innovent Receives Second Fast Track Designation From the U.S. FDA for Ibi363 (Pd-1/Il-2Α-Bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer

THOMSON REUTERS

Innovent Biologics' Near-Term Stock Performance May Depend on New Drug Products -- Market Talk

Innovent Biologics Logs 25% Boost in Q4 2024 Product Revenue

MT Newswires Live

Innovent Biologics - Expected Result Due to Continued Fast Growth of Major Products, Others

THOMSON REUTERS

Innovent Biologics - for FY Total Product Revenue Amounted to More Than RMB8.2 Bln

THOMSON REUTERS

Stock Track | Innovent Biologics Soars 5% as New Lung Cancer Drug Limertinib Gets China Approval

Innovent Biologics Gets China Approval for Non-Small-Cell Lung Cancer Drug; Shares Rise 3%

MT Newswires Live

BUZZ-Innovent Biologics rises as regulator approves co's product for cancer treatment

BRIEF-Innovent Biologics Says Third-Generation EGFR TKI Limertinib Received Approval By NMPA China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01801/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01801","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01801\",,,,,undefined,":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"INNOVENT BIO","latestPrice":79.3,"timestamp":1751506208930,"preClose":79.3,"halted":0,"volume":239469,"delay":0,"floatShares":1653000000,"shares":1653000000,"eps":-0.06375428873537954,"marketStatus":"Trading","change":0,"latestTime":"07-03 09:30:09","open":79,"high":79.75,"low":78.85,"amount":18928569,"amplitude":0.011349,"askPrice":79.65,"askSize":8000,"bidPrice":79.2,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.06578711044822984,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1751515200000},"marketStatusCode":2,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":79.3,"openAndCloseTimeList":[[1751506200000,1751515200000],[1751518800000,1751529600000]],"volumeRatio":2.61583,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.6051,"impliedVolPercentile":0.6707},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01801\",,,,,undefined,":{"symbol":"01801","floatShares":1653000000,"roa":"-0.82%","roe":"-0.74%","lyrEps":-0.063754,"volumeRatio":2.621292,"shares":1653000000,"dividePrice":0,"high":79.75,"amplitude":0.011349,"preClose":79.3,"low":78.85,"week52Low":28.65,"pbRate":"9.15","psRate":"12.74","week52High":83.8,"institutionHeld":0,"latestPrice":79.65,"committee":-0.647059,"eps":-0.06375428873537954,"divideRate":0,"volume":239969,"delay":0,"ttmEps":-0.06578711044822984,"open":79,"prevYearClose":36.6,"prevWeekClose":77.35,"prevMonthClose":78.4,"prevQuarterClose":78.4,"fiveDayClose":82.4,"twentyDayClose":74.25,"sixtyDayClose":49.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01801\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520966229","title":"Innovent and HUTCHMED Jointly Announce That the Frusica-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2520966229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520966229?lang=en_us&edition=fundamental","pubTime":"2025-03-19 08:55","pubTimestamp":1742345746,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA1SPKVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01801","LU1969619763.USD","LU2328871848.SGD","LU2488822045.USD","BK1583","BK1589"],"gpt_icon":0},{"id":"2519751338","title":"Innovent Biologics' NDA for Thyroid Eye Disease Drug Gets China Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2519751338","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519751338?lang=en_us&edition=fundamental","pubTime":"2025-03-14 17:54","pubTimestamp":1741946041,"startTime":"0","endTime":"0","summary":"Innovent Biologics' (HKG:1801) new drug application (NDA) for teprotumumab N01 injection under the brand name, SYCUME, has received approval from China's National Medical Products Administration for the treatment of thyroid eye disease, a Friday filing with the Hong Kong bourse said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1969619763.USD","LU2488822045.USD","BK1583","BK1589","LU2328871848.SGD","BK1161","01801"],"gpt_icon":0},{"id":"2519994829","title":"Innovent Biologics - Igf-1R Monoclonal Antibody Sycume Received Approval by Nmpa for Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2519994829","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519994829?lang=en_us&edition=fundamental","pubTime":"2025-03-14 16:31","pubTimestamp":1741941070,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01801","LU1969619763.USD","LU2328871848.SGD","LU2488822045.USD","BK1583","BK1589"],"gpt_icon":0},{"id":"2518758712","title":"BRIEF-Innovent Is Said To Consider Licensing Partnership For Cancer Drug- Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2518758712","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518758712?lang=en_us&edition=fundamental","pubTime":"2025-03-11 11:09","pubTimestamp":1741662578,"startTime":"0","endTime":"0","summary":"BRIEF-Innovent Is Said To Consider Licensing Partnership For Cancer Drug- Bloomberg NewsMarch 10 (Reuters) - INNOVENT IS SAID TO CONSIDER LICENSING PARTNERSHIP FOR CANCER DRUG- BLOOMBERG NEWSSource: https://tinyurl.com/aefzwbea ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU05K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU2488822045.USD","BK1583","BK1161","BK1589","LU2328871848.SGD","01801"],"gpt_icon":0},{"id":"2518582217","title":"Innovent Is Said to Consider Licensing Partnership for Cancer Drug- Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2518582217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518582217?lang=en_us&edition=fundamental","pubTime":"2025-03-11 11:08","pubTimestamp":1741662532,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU05K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK1589","LU2328871848.SGD","BK1161","01801","BK1583","LU1969619763.USD"],"gpt_icon":0},{"id":"2516452302","title":"Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of Ibi363 (Pd-1/Il-2Α-Bias Bispecific Antibody Fusion Protein) in Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2516452302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516452302?lang=en_us&edition=fundamental","pubTime":"2025-03-03 08:00","pubTimestamp":1740960005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUAK75Z7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01801","BK1161","LU2328871848.SGD","BK1583","LU2488822045.USD","BK1589","LU1969619763.USD"],"gpt_icon":0},{"id":"2513999917","title":"Innovent Biologics Anti-Cancer Drug's NDA Accepted by China's NMPA; Shares Slide 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513999917","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513999917?lang=en_us&edition=fundamental","pubTime":"2025-02-24 11:24","pubTimestamp":1740367451,"startTime":"0","endTime":"0","summary":"Innovent Biologics  said the new drug application for its anti-cancer drug ipilimumab injection \"CTLA-4\" monoclonal antibody was accepted by the Center for Drug Evaluation of the National Medical Products Administration of China, according to a Monday filing with the Hong Kong bourse.The medicine also received a Priority Review designation in combination with sintilimab as neoadjuvant treatment for resectable microsatellite instability-high or mismatch repair deficient  colon cancer. This is China's first NDA for a domestic CTLA-4 inhibitor, the filing added.The company's share prices were down over 3% in recent trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1589","LU2328871848.SGD","01801","LU2488822045.USD","BK1161","LU1969619763.USD","BK1583"],"gpt_icon":0},{"id":"2513767583","title":"BRIEF-Innovent Biologics Says NMPA China Accepts New Drug Application For Ipilimumab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2513767583","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513767583?lang=en_us&edition=fundamental","pubTime":"2025-02-24 09:26","pubTimestamp":1740360397,"startTime":"0","endTime":"0","summary":"BRIEF-Innovent Biologics Says NMPA China Accepts New Drug Application For Ipilimumab InjectionFeb 24  - Innovent Biologics Inc 1801.HK:NMPA CHINA ACCEPTS NEW DRUG APPLICATION & GRANTS PRIORITY REVIEW DESIGNATION TO IPILIMUMAB INJECTIONFurther company coverage: 1801.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PD08T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","BK1161","LU2328871848.SGD","LU1969619763.USD","LU2488822045.USD","01801"],"gpt_icon":0},{"id":"2513769941","title":"Nmpa Accepts Nda and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic Ctla-4 Inhibitor, in Combination With Sintilimab as Neoadjuvant Treatment for Colon Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2513769941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513769941?lang=en_us&edition=fundamental","pubTime":"2025-02-24 07:51","pubTimestamp":1740354662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250223:nTUA9LLZNY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1969619763.USD","LU2488822045.USD","BK1583","BK1589","LU2328871848.SGD","BK1161","01801"],"gpt_icon":0},{"id":"2513746766","title":"Innovent Biologics - Nmpa China Accepts New Drug Application & Grants Priority Review Designation to Ipilimumab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2513746766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513746766?lang=en_us&edition=fundamental","pubTime":"2025-02-24 07:31","pubTimestamp":1740353462,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250223:nFWN3PD08T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1161","LU2328871848.SGD","LU1969619763.USD","01801","BK1589","LU2488822045.USD"],"gpt_icon":0},{"id":"2512365441","title":"Nomura Adjusts Innovent Biologics' Price Target to HK$54.60 From HK$58.09, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2512365441","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512365441?lang=en_us&edition=fundamental","pubTime":"2025-02-18 16:30","pubTimestamp":1739867432,"startTime":"0","endTime":"0","summary":"Nomura Adjusts Innovent Biologics' Price Target to HK$54.60 From HK$58.09, Keeps at Buy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMR","01801"],"gpt_icon":0},{"id":"2512965542","title":"Innovent Receives Second Fast Track Designation From the U.S. FDA for Ibi363 (Pd-1/Il-2Α-Bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2512965542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512965542?lang=en_us&edition=fundamental","pubTime":"2025-02-17 08:00","pubTimestamp":1739750405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250217:nTUA2DNCYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2328871848.SGD","BK1161","BK1583","LU2488822045.USD","01801","BK1589","LU1969619763.USD"],"gpt_icon":0},{"id":"2510283680","title":"Innovent Biologics' Near-Term Stock Performance May Depend on New Drug Products -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2510283680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510283680?lang=en_us&edition=fundamental","pubTime":"2025-02-10 17:08","pubTimestamp":1739178480,"startTime":"0","endTime":"0","summary":"0908 GMT - Innovent Biologics' near-term stock performance may depend on the approval and sales of its potential blockbuster drug Mazdutide in 1H2025, according to Deutsche Bank Research analyst Cyrus Ng in a commentary. The biotech company's share price has rebounded 14% since January 25, outperforming its peers' average of 4.9% during the same period, Ng says. However, revenue growth slowed in Q4 compared to the previous quarter, although 2024 product sales remain in line with expectations, the analyst notes. Ng maintains a buy rating and a target price of HK$49.00. Shares were last up 0.3% at HK$36.35. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1589","01801","BK1583","LU1969619763.USD","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"2509226683","title":"Innovent Biologics Logs 25% Boost in Q4 2024 Product Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2509226683","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509226683?lang=en_us&edition=fundamental","pubTime":"2025-02-06 19:01","pubTimestamp":1738839675,"startTime":"0","endTime":"0","summary":"Innovent Biologics  recorded a total product revenue of 2 billion yuan or more in the fourth quarter of 2024, up at least 25% from a year prior, a Thursday bourse filing said.In full-year 2024, product revenue grew by at least 40% to 8.2 billion yuan.The drug company attributed the rise in revenue mainly to its leading position in the oncology niche, fast growth of major products, and the strong ramp-up momentum of new products.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01801"],"gpt_icon":0},{"id":"2509242015","title":"Innovent Biologics - Expected Result Due to  Continued Fast Growth of Major Products, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2509242015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509242015?lang=en_us&edition=fundamental","pubTime":"2025-02-06 17:30","pubTimestamp":1738834238,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0S4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1583","LU2488822045.USD","LU2328871848.SGD","LU1969619763.USD","BK1161","01801"],"gpt_icon":0},{"id":"2509016242","title":"Innovent Biologics - for FY Total Product Revenue Amounted to More Than RMB8.2 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2509016242","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509016242?lang=en_us&edition=fundamental","pubTime":"2025-02-06 17:30","pubTimestamp":1738834238,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK1589","01801","BK1583","LU2328871848.SGD","LU1969619763.USD","BK1161"],"gpt_icon":0},{"id":"1155965391","title":"Stock Track | Innovent Biologics Soars 5% as New Lung Cancer Drug Limertinib Gets China Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1155965391","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155965391?lang=en_us&edition=fundamental","pubTime":"2025-01-17 13:26","pubTimestamp":1737091615,"startTime":"0","endTime":"0","summary":"Hong Kong-listed biotech firm Innovent Biologics  saw its shares soar 5.17% in intraday trading on Friday, following news that its third-generation EGFR TKI drug Limertinib received approval from China's medical regulator NMPA for treatment of a certain mutation in non-small cell lung cancer.Limertinib targets the EGFR T790M mutation, which is present in up to 50% of Asian lung cancer patients with locally advanced or metastatic non-small cell lung cancer. This regulatory milestone clears the wa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Innovent Biologics Soars 5% as New Lung Cancer Drug Limertinib Gets China Approval","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01801"],"gpt_icon":1},{"id":"2504901404","title":"Innovent Biologics Gets China Approval for Non-Small-Cell Lung Cancer Drug; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504901404","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504901404?lang=en_us&edition=fundamental","pubTime":"2025-01-17 12:48","pubTimestamp":1737089305,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved Innovent Biologics'  limertinib for a mutation of locally advanced or metastatic non-small cell lung cancer, according to a Friday filing with the Hong Kong Exchange.The drug is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.It is indicated for the EGFR T790M mutation, which is the most common mutation and affects up to 50% of Asian patients of the disease, the filing said.Shares rose 3% during Friday's late morning trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2488822045.USD","BK1589","LU1969619763.USD","01801","BK1583","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"2504090532","title":"BUZZ-Innovent Biologics rises as regulator approves co's product for cancer treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2504090532","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504090532?lang=en_us&edition=fundamental","pubTime":"2025-01-17 11:41","pubTimestamp":1737085291,"startTime":"0","endTime":"0","summary":"BUZZ-Innovent Biologics rises as regulator approves co's product for cancer treatment** Shares of Innovent Biologics Inc 1801.HK rise 3.3% to HK$31, on course to snap two consecutive session of decline** Stock on track for the biggest one-day jump since Dec. 9, 2024; among top 10 gainers in healthcare index .HSCIH, which is up 0.8%** Innovent says new drug application of limertinib - the third-generation epidermal growth factor receptor tyrosine kinase inhibitor, has received approval by National Medical Products Administration of China  for treatment of lung cancer** Hang Seng Commerce & Industry Index .HSNC and Hang Seng Index .HSI boht slip 0.1%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250117:nL1N3OD04X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","01911","BK1589","01801","BK1583","LU1969619763.USD","BK1161","LU2328871848.SGD","BK1147"],"gpt_icon":0},{"id":"2504761649","title":"BRIEF-Innovent Biologics Says Third-Generation EGFR TKI Limertinib Received Approval By NMPA China","url":"https://stock-news.laohu8.com/highlight/detail?id=2504761649","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504761649?lang=en_us&edition=fundamental","pubTime":"2025-01-17 09:33","pubTimestamp":1737077623,"startTime":"0","endTime":"0","summary":"BRIEF-Innovent Biologics Says Third-Generation EGFR TKI Limertinib Received Approval By NMPA ChinaJan 17 (Reuters) - Innovent Biologics Inc 1801.HK:THIRD-GENERATION EGFR TKI LIMERTINIB RECEIVED APPROVAL BY NMPA CHINAFurther company coverage: 1801.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250117:nFWN3OC1KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2488822045.USD","LU2328871848.SGD","BK1583","BK1589","01801","LU1969619763.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":82,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01801\",params:#limit:5,,,undefined,":[{"date":"2025-03-26","symbol":"01801","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Post Market","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-28","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-20","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710898200000,"name":null,"time":"","dateTimestamp":1710864000000,"actualEps":null},{"date":"2023-08-23","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692754200000,"name":null,"time":"","dateTimestamp":1692720000000,"actualEps":null},{"date":"2023-03-28","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679967000000,"name":null,"time":"","dateTimestamp":1679932800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01801\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01801\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.5385,"hold":0.0385,"sell":0.0385,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":26,"updateTime":1751299200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01801\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01801","date":"2025-07-02","current":-1263.361744,"percent":0.005691,"low":-1314.719354,"twenty":-61.083148,"median":-43.91364,"eighty":-19.437399,"high":-7.531991,"avg":-90.46625,"sd":210.904775,"marketCap":130970767976},"quantilePoints":[{"date":"2020-07-03","current":-42.15165,"twenty":-31.212367,"median":-21.5439,"eighty":-5.426457,"marketCap":79513042032},{"date":"2020-07-10","current":-41.718218,"twenty":-33.055097,"median":-23.009394,"eighty":-5.428958,"marketCap":79445885746},{"date":"2020-07-17","current":-36.617176,"twenty":-33.853843,"median":-23.56045,"eighty":-5.435413,"marketCap":69842536920},{"date":"2020-07-24","current":-35.392158,"twenty":-34.117248,"median":-23.759204,"eighty":-5.43938,"marketCap":67241749424},{"date":"2020-07-31","current":-34.790809,"twenty":-34.526864,"median":-24.13478,"eighty":-5.448361,"marketCap":66487246107},{"date":"2020-08-07","current":-36.619021,"twenty":-34.926791,"median":-24.303633,"eighty":-5.465712,"marketCap":70056561424},{"date":"2020-08-14","current":-36.782836,"twenty":-35.235669,"median":-24.961961,"eighty":-5.472343,"marketCap":70546467448},{"date":"2020-08-21","current":-40.576246,"twenty":-35.792876,"median":-25.584933,"eighty":-5.486343,"marketCap":78175004107},{"date":"2020-08-28","current":-43.795492,"twenty":-36.439174,"median":-26.421678,"eighty":-5.520251,"marketCap":79784695329},{"date":"2020-09-04","current":-39.665739,"twenty":-36.777743,"median":-27.271989,"eighty":-5.526185,"marketCap":72506091544},{"date":"2020-09-11","current":-42.988967,"twenty":-37.537428,"median":-27.599103,"eighty":-5.541887,"marketCap":78664910131},{"date":"2020-09-18","current":-47.462616,"twenty":-38.638915,"median":-28.066584,"eighty":-5.578764,"marketCap":87693178287},{"date":"2020-09-25","current":-44.177192,"twenty":-39.337069,"median":-29.168327,"eighty":-5.58909,"marketCap":80974467101},{"date":"2020-09-30","current":-43.635669,"twenty":-39.577106,"median":-29.30153,"eighty":-5.589358,"marketCap":80363386427},{"date":"2020-10-09","current":-45.526878,"twenty":-40.068119,"median":-30.400474,"eighty":-5.594485,"marketCap":85053584067},{"date":"2020-10-16","current":-50.643672,"twenty":-40.933846,"median":-30.680202,"eighty":-5.627514,"marketCap":94573985247},{"date":"2020-10-23","current":-47.907898,"twenty":-41.325791,"median":-32.326031,"eighty":-5.801767,"marketCap":89603775808},{"date":"2020-10-30","current":-42.811074,"twenty":-41.735504,"median":-32.968835,"eighty":-5.84909,"marketCap":80083374628},{"date":"2020-11-06","current":-42.967789,"twenty":-42.743927,"median":-33.29142,"eighty":-5.864706,"marketCap":81316323725},{"date":"2020-11-13","current":-40.934902,"twenty":-42.378258,"median":-33.900554,"eighty":-5.91801,"marketCap":77534169133},{"date":"2020-11-20","current":-41.561739,"twenty":-42.114631,"median":-34.056118,"eighty":-5.952614,"marketCap":79215126730},{"date":"2020-11-27","current":-38.270387,"twenty":-41.89284,"median":-34.145822,"eighty":-5.961576,"marketCap":72771455944},{"date":"2020-12-04","current":-42.094411,"twenty":-41.89284,"median":-34.507897,"eighty":-5.975351,"marketCap":80618802227},{"date":"2020-12-11","current":-41.498839,"twenty":-41.89284,"median":-34.562136,"eighty":-6.024626,"marketCap":79287996630},{"date":"2020-12-18","current":-49.483759,"twenty":-42.135729,"median":-34.875798,"eighty":-6.083138,"marketCap":94697324597},{"date":"2020-12-24","current":-53.344979,"twenty":-42.79967,"median":-35.04397,"eighty":-6.115628,"marketCap":102191861381},{"date":"2020-12-31","current":-60.05736,"twenty":-43.169204,"median":-35.327908,"eighty":-6.141418,"marketCap":115097770553},{"date":"2021-01-08","current":-59.811501,"twenty":-59.909844,"median":-58.854704,"eighty":-57.04374,"marketCap":115658880952},{"date":"2021-01-15","current":-65.889833,"twenty":-65.542577,"median":-59.934431,"eighty":-58.653787,"marketCap":127231897878},{"date":"2021-01-22","current":-75.111578,"twenty":-69.798545,"median":-61.62536,"eighty":-58.836696,"marketCap":144977859301},{"date":"2021-01-29","current":-66.268267,"twenty":-70.935369,"median":-65.600453,"eighty":-58.920414,"marketCap":128966248334},{"date":"2021-02-05","current":-70.843724,"twenty":-71.160691,"median":-66.402516,"eighty":-59.472589,"marketCap":137044833867},{"date":"2021-02-11","current":-73.259421,"twenty":-72.388775,"median":-68.623378,"eighty":-59.909845,"marketCap":141921097207},{"date":"2021-02-19","current":-69.584878,"twenty":-72.910639,"median":-69.283721,"eighty":-60.353226,"marketCap":134861432372},{"date":"2021-02-26","current":-60.141164,"twenty":-72.481128,"median":-68.087003,"eighty":-60.420269,"marketCap":116302519660},{"date":"2021-03-05","current":-56.85889,"twenty":-72.0166,"median":-66.268267,"eighty":-60.074121,"marketCap":109679535123},{"date":"2021-03-12","current":-59.415349,"twenty":-71.520469,"median":-65.634307,"eighty":-59.099919,"marketCap":114410238364},{"date":"2021-03-19","current":-58.603337,"twenty":-71.014965,"median":-65.279781,"eighty":-58.980041,"marketCap":112809077267},{"date":"2021-03-26","current":-57.420101,"twenty":-70.801528,"median":-63.675052,"eighty":-58.456619,"marketCap":110043435373},{"date":"2021-04-01","current":-99.513447,"twenty":-72.111714,"median":-65.255751,"eighty":-58.603337,"marketCap":117685340607},{"date":"2021-04-09","current":-93.829103,"twenty":-73.100725,"median":-65.311073,"eighty":-58.727146,"marketCap":111207916170},{"date":"2021-04-16","current":-91.762285,"twenty":-74.85113,"median":-65.783649,"eighty":-58.836696,"marketCap":109170074775},{"date":"2021-04-23","current":-109.839824,"twenty":-90.431092,"median":-66.402516,"eighty":-58.920414,"marketCap":131004089730},{"date":"2021-04-30","current":-102.619464,"twenty":-91.452277,"median":-68.724058,"eighty":-59.011683,"marketCap":122897013046},{"date":"2021-05-07","current":-97.428671,"twenty":-96.409896,"median":-69.352117,"eighty":-59.213107,"marketCap":117436541495},{"date":"2021-05-14","current":-101.964808,"twenty":-97.632955,"median":-70.026533,"eighty":-59.379727,"marketCap":122824206759},{"date":"2021-05-21","current":-109.973218,"twenty":-99.103595,"median":-70.738235,"eighty":-59.57381,"marketCap":132507442977},{"date":"2021-05-28","current":-107.105119,"twenty":-100.222008,"median":-71.636143,"eighty":-59.909845,"marketCap":130323254356},{"date":"2021-06-04","current":-106.183195,"twenty":-103.047548,"median":-72.784205,"eighty":-60.090882,"marketCap":128588964422},{"date":"2021-06-11","current":-108.23655,"twenty":-104.283306,"median":-74.011578,"eighty":-60.308104,"marketCap":131066032292},{"date":"2021-06-18","current":-104.996815,"twenty":-104.950024,"median":-74.677498,"eighty":-60.754148,"marketCap":126111896552},{"date":"2021-06-25","current":-108.401163,"twenty":-105.285659,"median":-75.279371,"eighty":-61.553193,"marketCap":130118918107},{"date":"2021-07-02","current":-106.622678,"twenty":-106.183195,"median":-90.445668,"eighty":-61.619211,"marketCap":127760482537},{"date":"2021-07-09","current":-100.272231,"twenty":-106.183195,"median":-90.948745,"eighty":-61.62536,"marketCap":120030681653},{"date":"2021-07-16","current":-106.975494,"twenty":-106.622678,"median":-92.795694,"eighty":-61.712678,"marketCap":128052173136},{"date":"2021-07-23","current":-102.477274,"twenty":-106.622678,"median":-96.369361,"eighty":-62.277177,"marketCap":122655897047},{"date":"2021-07-30","current":-96.244101,"twenty":-106.531079,"median":-96.160202,"eighty":-62.43474,"marketCap":115582400012},{"date":"2021-08-06","current":-90.456671,"twenty":-106.183195,"median":-96.076303,"eighty":-63.026939,"marketCap":108369781827},{"date":"2021-08-13","current":-89.117798,"twenty":-106.148472,"median":-94.251891,"eighty":-64.323165,"marketCap":106911238330},{"date":"2021-08-20","current":-76.56893,"twenty":-106.141613,"median":-92.830432,"eighty":-65.231721,"marketCap":91596531611},{"date":"2021-08-27","current":-52.912902,"twenty":-105.631697,"median":-91.452399,"eighty":-63.026939,"marketCap":88752371792},{"date":"2021-09-03","current":-57.411891,"twenty":-105.383527,"median":-90.623704,"eighty":-61.62536,"marketCap":96337788726},{"date":"2021-09-10","current":-55.660683,"twenty":-105.292659,"median":-90.464692,"eighty":-60.141164,"marketCap":93639455507},{"date":"2021-09-17","current":-57.825782,"twenty":-105.258722,"median":-90.168186,"eighty":-59.326295,"marketCap":96994140050},{"date":"2021-09-24","current":-63.057451,"twenty":-105.257871,"median":-87.790274,"eighty":-59.397538,"marketCap":105818418957},{"date":"2021-09-30","current":-65.454027,"twenty":-105.205276,"median":-86.731586,"eighty":-59.427942,"marketCap":110207765023},{"date":"2021-10-08","current":-65.977203,"twenty":-105.066231,"median":-82.434007,"eighty":-59.619544,"marketCap":111083588321},{"date":"2021-10-15","current":-66.495128,"twenty":-104.917441,"median":-78.481513,"eighty":-59.76961,"marketCap":112032396894},{"date":"2021-10-22","current":-65.935102,"twenty":-104.784173,"median":-75.402004,"eighty":-59.909845,"marketCap":111886426345},{"date":"2021-10-29","current":-60.1915,"twenty":-104.573848,"median":-74.894538,"eighty":-59.969027,"marketCap":101887443690},{"date":"2021-11-05","current":-59.419571,"twenty":-104.241823,"median":-74.011578,"eighty":-59.426278,"marketCap":100746520293},{"date":"2021-11-12","current":-64.535702,"twenty":-104.144247,"median":-72.784205,"eighty":-59.558476,"marketCap":109872110899},{"date":"2021-11-19","current":-68.964255,"twenty":-103.89668,"median":-71.636143,"eighty":-59.76961,"marketCap":117245588109},{"date":"2021-11-26","current":-63.104,"twenty":-103.574286,"median":-70.738235,"eighty":-59.868596,"marketCap":107316945529},{"date":"2021-12-03","current":-56.970022,"twenty":-103.502791,"median":-69.584878,"eighty":-59.426278,"marketCap":97064410689},{"date":"2021-12-10","current":-56.787261,"twenty":-103.406584,"median":-69.317919,"eighty":-59.328306,"marketCap":96918229348},{"date":"2021-12-17","current":-46.241205,"twenty":-103.373136,"median":-68.872296,"eighty":-58.827693,"marketCap":78864833685},{"date":"2021-12-24","current":-42.300946,"twenty":-103.099197,"median":-68.604599,"eighty":-58.435519,"marketCap":72213582651},{"date":"2021-12-31","current":-41.234857,"twenty":-102.722762,"median":-67.767406,"eighty":-58.065904,"marketCap":70546743038},{"date":"2022-01-07","current":-34.486195,"twenty":-40.275969,"median":-37.64864,"eighty":-34.378339,"marketCap":58776768292},{"date":"2022-01-14","current":-37.878055,"twenty":-39.829817,"median":-37.763347,"eighty":-34.687526,"marketCap":64698308382},{"date":"2022-01-21","current":-35.699125,"twenty":-39.504145,"median":-36.722111,"eighty":-34.943651,"marketCap":61116142155},{"date":"2022-01-28","current":-26.329119,"twenty":-38.684591,"median":-35.628932,"eighty":-34.378339,"marketCap":44959841418},{"date":"2022-02-04","current":-26.846632,"twenty":-38.167145,"median":-35.414472,"eighty":-33.988231,"marketCap":45821080875},{"date":"2022-02-11","current":-27.092592,"twenty":-37.878055,"median":-35.02492,"eighty":-28.311865,"marketCap":46334276980},{"date":"2022-02-18","current":-29.050449,"twenty":-37.64864,"median":-34.653971,"eighty":-28.311865,"marketCap":49926649721},{"date":"2022-02-25","current":-29.744971,"twenty":-36.735769,"median":-33.988231,"eighty":-27.979692,"marketCap":51246296850},{"date":"2022-03-04","current":-27.223879,"twenty":-36.722111,"median":-29.802166,"eighty":-27.979692,"marketCap":46920786816},{"date":"2022-03-11","current":-23.132687,"twenty":-36.621639,"median":-29.36929,"eighty":-27.223879,"marketCap":39809355064},{"date":"2022-03-18","current":-23.353608,"twenty":-35.699125,"median":-29.07698,"eighty":-26.329119,"marketCap":40029296252},{"date":"2022-03-25","current":-23.609253,"twenty":-35.558739,"median":-28.622989,"eighty":-24.861144,"marketCap":40469178628},{"date":"2022-04-01","current":-10.302966,"twenty":-35.270205,"median":-28.485417,"eighty":-23.573298,"marketCap":39809355064},{"date":"2022-04-08","current":-10.829548,"twenty":-35.143591,"median":-28.187716,"eighty":-23.264469,"marketCap":41862139487},{"date":"2022-04-14","current":-10.543533,"twenty":-35.059727,"median":-27.88961,"eighty":-22.413734,"marketCap":40689119817},{"date":"2022-04-22","current":-10.163583,"twenty":-34.960508,"median":-27.608169,"eighty":-14.664685,"marketCap":38489707935},{"date":"2022-04-29","current":-9.896969,"twenty":-34.847033,"median":-27.171587,"eighty":-10.835566,"marketCap":36876805888},{"date":"2022-05-06","current":-7.794072,"twenty":-34.754637,"median":-27.092592,"eighty":-10.351079,"marketCap":28800028988},{"date":"2022-05-13","current":-7.531991,"twenty":-34.486195,"median":-26.329119,"eighty":-10.163583,"marketCap":27333632400},{"date":"2022-05-20","current":-9.06555,"twenty":-34.216555,"median":-24.981857,"eighty":-9.94212,"marketCap":33360522377},{"date":"2022-05-27","current":-8.694531,"twenty":-33.988231,"median":-24.386135,"eighty":-9.493302,"marketCap":31967445618},{"date":"2022-06-02","current":-9.642455,"twenty":-32.008842,"median":-23.573298,"eighty":-9.445349,"marketCap":35642983659},{"date":"2022-06-10","current":-10.68648,"twenty":-30.190287,"median":-23.325512,"eighty":-9.612624,"marketCap":39236617814},{"date":"2022-06-17","current":-10.7582,"twenty":-29.767849,"median":-23.119688,"eighty":-9.67054,"marketCap":39456636231},{"date":"2022-06-24","current":-14.400248,"twenty":-29.698416,"median":-20.893648,"eighty":-9.677673,"marketCap":53024438653},{"date":"2022-06-30","current":-13.932533,"twenty":-29.496285,"median":-17.024829,"eighty":-9.74948,"marketCap":51213898589},{"date":"2022-07-08","current":-14.67593,"twenty":-29.3239,"median":-15.17553,"eighty":-9.857114,"marketCap":54002047796},{"date":"2022-07-15","current":-14.83334,"twenty":-29.179562,"median":-14.952896,"eighty":-9.904546,"marketCap":54075420144},{"date":"2022-07-22","current":-14.019077,"twenty":-29.071673,"median":-14.83334,"eighty":-9.929111,"marketCap":51140526242},{"date":"2022-07-29","current":-13.158261,"twenty":-28.820464,"median":-14.63277,"eighty":-9.965579,"marketCap":48058887645},{"date":"2022-08-05","current":-14.452099,"twenty":-28.640649,"median":-14.521363,"eighty":-10.047766,"marketCap":52650020045},{"date":"2022-08-12","current":-14.71463,"twenty":-28.603223,"median":-14.534456,"eighty":-10.093451,"marketCap":53679489711},{"date":"2022-08-19","current":-14.001057,"twenty":-28.570837,"median":-14.521363,"eighty":-10.095676,"marketCap":50565103155},{"date":"2022-08-26","current":-15.136454,"twenty":-28.470894,"median":-14.486731,"eighty":-10.136779,"marketCap":53314867072},{"date":"2022-09-02","current":-13.75829,"twenty":-28.35224,"median":-14.400248,"eighty":-10.174316,"marketCap":48286589223},{"date":"2022-09-09","current":-12.67453,"twenty":-28.162886,"median":-14.340141,"eighty":-10.188715,"marketCap":44313642009},{"date":"2022-09-16","current":-11.97665,"twenty":-28.030016,"median":-14.29062,"eighty":-10.196162,"marketCap":41486737260},{"date":"2022-09-23","current":-10.816798,"twenty":-27.907626,"median":-14.221409,"eighty":-10.24124,"marketCap":36749761735},{"date":"2022-09-30","current":-10.989799,"twenty":-27.744526,"median":-14.086255,"eighty":-10.312544,"marketCap":37408857483},{"date":"2022-10-07","current":-10.967956,"twenty":-27.640481,"median":-14.000529,"eighty":-10.336741,"marketCap":37332356752},{"date":"2022-10-14","current":-11.448997,"twenty":-27.488229,"median":-13.89571,"eighty":-10.263806,"marketCap":38556368449},{"date":"2022-10-21","current":-13.815232,"twenty":-27.213421,"median":-13.759398,"eighty":-10.307755,"marketCap":46206441554},{"date":"2022-10-28","current":-12.395469,"twenty":-27.165938,"median":-13.60575,"eighty":-10.336584,"marketCap":41386895498},{"date":"2022-11-04","current":-14.340639,"twenty":-27.133191,"median":-13.618391,"eighty":-10.375435,"marketCap":48347495967},{"date":"2022-11-11","current":-14.799648,"twenty":-27.0434,"median":-13.75829,"eighty":-10.403849,"marketCap":50339627338},{"date":"2022-11-18","current":-14.669694,"twenty":-26.743129,"median":-13.855471,"eighty":-10.5207,"marketCap":49726663840},{"date":"2022-11-25","current":-12.759206,"twenty":-26.31944,"median":-13.760506,"eighty":-10.550481,"marketCap":42907444916},{"date":"2022-12-02","current":-12.446274,"twenty":-26.045094,"median":-13.719165,"eighty":-10.589876,"marketCap":42577469882},{"date":"2022-12-09","current":-14.33147,"twenty":-25.054285,"median":-13.649228,"eighty":-10.646322,"marketCap":49481924457},{"date":"2022-12-16","current":-14.387249,"twenty":-24.801403,"median":-13.759398,"eighty":-10.697091,"marketCap":49558640619},{"date":"2022-12-23","current":-14.560885,"twenty":-24.527177,"median":-13.788181,"eighty":-10.74327,"marketCap":50172369915},{"date":"2022-12-30","current":-14.738058,"twenty":-24.421396,"median":-13.826106,"eighty":-10.754467,"marketCap":51399828506},{"date":"2023-01-06","current":-14.850279,"twenty":-23.920006,"median":-13.912069,"eighty":-10.764544,"marketCap":52323278120},{"date":"2023-01-13","current":-18.011522,"twenty":-23.58768,"median":-13.988706,"eighty":-10.797588,"marketCap":64675254333},{"date":"2023-01-20","current":-18.576885,"twenty":-23.451175,"median":-14.010067,"eighty":-10.824448,"marketCap":66132940967},{"date":"2023-01-27","current":-20.253712,"twenty":-23.369759,"median":-14.086255,"eighty":-10.829548,"marketCap":72117128201},{"date":"2023-02-03","current":-19.550889,"twenty":-23.353608,"median":-14.221409,"eighty":-10.844594,"marketCap":69975086836},{"date":"2023-02-10","current":-18.461328,"twenty":-23.297415,"median":-14.245235,"eighty":-10.967956,"marketCap":65678370978},{"date":"2023-02-17","current":-17.287694,"twenty":-23.132687,"median":-14.283163,"eighty":-10.989799,"marketCap":60921292706},{"date":"2023-02-24","current":-16.928562,"twenty":-23.119688,"median":-14.316312,"eighty":-11.024034,"marketCap":58926388915},{"date":"2023-03-03","current":-18.506493,"twenty":-22.859931,"median":-14.340639,"eighty":-11.034338,"marketCap":64834373220},{"date":"2023-03-10","current":-17.143751,"twenty":-18.007033,"median":-17.594016,"eighty":-17.406062,"marketCap":59616932535},{"date":"2023-03-17","current":-18.225066,"twenty":-64.535702,"median":-27.223879,"eighty":-8.33302,"marketCap":63990375462},{"date":"2023-03-24","current":-16.635504,"twenty":-64.428087,"median":-27.157464,"eighty":-8.3397,"marketCap":59079843053},{"date":"2023-03-31","current":-21.665543,"twenty":-64.392731,"median":-27.092592,"eighty":-8.34275,"marketCap":53939129436},{"date":"2023-04-06","current":-23.653196,"twenty":-64.390621,"median":-26.634155,"eighty":-8.352405,"marketCap":58849661846},{"date":"2023-04-14","current":-26.320033,"twenty":-64.362795,"median":-26.324576,"eighty":-8.358879,"marketCap":65549469340},{"date":"2023-04-21","current":-23.835896,"twenty":-64.30121,"median":-26.271674,"eighty":-8.365503,"marketCap":59332248009},{"date":"2023-04-28","current":-23.269102,"twenty":-64.264448,"median":-25.584933,"eighty":-8.381733,"marketCap":57490108356},{"date":"2023-05-05","current":-25.40213,"twenty":-64.226366,"median":-25.443671,"eighty":-8.392457,"marketCap":62863015679},{"date":"2023-05-12","current":-24.841882,"twenty":-63.995645,"median":-25.285405,"eighty":-8.397793,"marketCap":61053226682},{"date":"2023-05-19","current":-24.150302,"twenty":-63.567828,"median":-25.133368,"eighty":-8.401129,"marketCap":58518941801},{"date":"2023-05-25","current":-24.040915,"twenty":-63.478503,"median":-25.133368,"eighty":-8.403051,"marketCap":57981366220},{"date":"2023-06-02","current":-23.630086,"twenty":-63.473336,"median":-25.04176,"eighty":-8.412356,"marketCap":56829418547},{"date":"2023-06-09","current":-24.154309,"twenty":-63.449017,"median":-24.911552,"eighty":-8.424162,"marketCap":58006344624},{"date":"2023-06-16","current":-23.65814,"twenty":-63.399642,"median":-24.844401,"eighty":-8.424971,"marketCap":56542705118},{"date":"2023-06-23","current":-19.736815,"twenty":-63.261636,"median":-24.800239,"eighty":-8.430589,"marketCap":46913497843},{"date":"2023-06-30","current":-19.361003,"twenty":-63.08538,"median":-24.583422,"eighty":-8.44223,"marketCap":45603925654},{"date":"2023-07-07","current":-19.824835,"twenty":-63.045246,"median":-24.39464,"eighty":-8.448328,"marketCap":46605363211},{"date":"2023-07-14","current":-20.972988,"twenty":-63.025798,"median":-24.281068,"eighty":-8.448858,"marketCap":49996366985},{"date":"2023-07-21","current":-21.298184,"twenty":-63.023861,"median":-24.205923,"eighty":-8.451759,"marketCap":50535619017},{"date":"2023-07-28","current":-23.791121,"twenty":-62.900857,"median":-24.161547,"eighty":-8.45846,"marketCap":56390355367},{"date":"2023-08-04","current":-21.285622,"twenty":-62.621827,"median":-24.152023,"eighty":-8.468652,"marketCap":50535619017},{"date":"2023-08-11","current":-21.635252,"twenty":-62.473049,"median":-24.087847,"eighty":-8.483716,"marketCap":51075672185},{"date":"2023-08-18","current":-20.673771,"twenty":-62.457914,"median":-23.929713,"eighty":-8.495975,"marketCap":48456406945},{"date":"2023-08-25","current":-35.378703,"twenty":-62.412077,"median":-24.023529,"eighty":-8.502433,"marketCap":52077155954},{"date":"2023-09-01","current":-36.587783,"twenty":-62.312576,"median":-24.142541,"eighty":-8.513294,"marketCap":54080524613},{"date":"2023-09-08","current":-37.287346,"twenty":-62.243984,"median":-24.154309,"eighty":-8.541071,"marketCap":54465713535},{"date":"2023-09-15","current":-41.061694,"twenty":-62.09617,"median":-24.166632,"eighty":-8.556024,"marketCap":60443963680},{"date":"2023-09-22","current":-41.150073,"twenty":-62.027557,"median":-24.212626,"eighty":-8.57503,"marketCap":60309214704},{"date":"2023-09-29","current":-41.957156,"twenty":-61.990984,"median":-24.362375,"eighty":-8.585232,"marketCap":61597529037},{"date":"2023-10-06","current":-42.818398,"twenty":-61.979722,"median":-24.399805,"eighty":-8.60704,"marketCap":62831819583},{"date":"2023-10-13","current":-48.929979,"twenty":-61.964165,"median":-24.604406,"eighty":-8.63324,"marketCap":71692717216},{"date":"2023-10-20","current":-48.564987,"twenty":-61.809044,"median":-24.821061,"eighty":-8.647132,"marketCap":71048288297},{"date":"2023-10-27","current":-49.577379,"twenty":-61.731951,"median":-24.852773,"eighty":-8.67951,"marketCap":72498253365},{"date":"2023-11-03","current":-50.935903,"twenty":-61.695214,"median":-24.911552,"eighty":-8.688438,"marketCap":74682635412},{"date":"2023-11-10","current":-51.497919,"twenty":-61.695214,"median":-24.911552,"eighty":-8.688438,"marketCap":75490889042},{"date":"2023-11-17","current":-48.797205,"twenty":-61.564351,"median":-24.911552,"eighty":-8.688438,"marketCap":72177049159},{"date":"2023-11-24","current":-47.423194,"twenty":-61.037754,"median":-24.911552,"eighty":-8.688438,"marketCap":70722192625},{"date":"2023-12-01","current":-47.541194,"twenty":-60.124403,"median":-24.911552,"eighty":-8.688438,"marketCap":71192149820},{"date":"2023-12-08","current":-43.123442,"twenty":-59.680613,"median":-24.911552,"eighty":-8.688438,"marketCap":64315635348},{"date":"2023-12-15","current":-45.518514,"twenty":-59.330317,"median":-24.911552,"eighty":-8.688438,"marketCap":68279743691},{"date":"2023-12-22","current":-41.339438,"twenty":-58.771185,"median":-24.911552,"eighty":-8.688438,"marketCap":61969530411},{"date":"2023-12-29","current":-45.897864,"twenty":-58.451098,"median":-24.911552,"eighty":-8.688438,"marketCap":69169645563},{"date":"2024-01-05","current":-41.6186,"twenty":-58.024001,"median":-24.911552,"eighty":-8.688438,"marketCap":62278306752},{"date":"2024-01-12","current":-43.437966,"twenty":-57.418459,"median":-24.911552,"eighty":-8.688438,"marketCap":65035419290},{"date":"2024-01-19","current":-39.267262,"twenty":-56.725823,"median":-24.911552,"eighty":-8.688438,"marketCap":58710278761},{"date":"2024-01-26","current":-36.31712,"twenty":-55.836725,"median":-24.911552,"eighty":-8.688438,"marketCap":54088060681},{"date":"2024-02-02","current":-34.853132,"twenty":-55.005219,"median":-24.911552,"eighty":-8.688438,"marketCap":51841523559},{"date":"2024-02-09","current":-39.078682,"twenty":-54.567045,"median":-24.977375,"eighty":-8.690942,"marketCap":58412984292},{"date":"2024-02-16","current":-43.519901,"twenty":-53.86795,"median":-24.961961,"eighty":-8.689273,"marketCap":65065574169},{"date":"2024-02-23","current":-43.423228,"twenty":-53.453001,"median":-24.961961,"eighty":-8.689273,"marketCap":64578799300},{"date":"2024-03-01","current":-43.287126,"twenty":-53.199825,"median":-24.969668,"eighty":-8.690107,"marketCap":64416541010},{"date":"2024-03-08","current":-42.88643,"twenty":-52.44341,"median":-24.969668,"eighty":-8.690107,"marketCap":63848636996},{"date":"2024-03-15","current":-46.524187,"twenty":-51.488905,"median":-25.009567,"eighty":-8.693429,"marketCap":69203160557},{"date":"2024-03-22","current":-52.308694,"twenty":-51.849485,"median":-25.232473,"eighty":-8.716682,"marketCap":58412984292},{"date":"2024-03-28","current":-54.97427,"twenty":-52.93553,"median":-25.488194,"eighty":-8.784794,"marketCap":61171375216},{"date":"2024-04-05","current":-52.146452,"twenty":-52.985136,"median":-25.87886,"eighty":-8.870004,"marketCap":58007338567},{"date":"2024-04-12","current":-54.452719,"twenty":-53.302804,"median":-26.375398,"eighty":-8.942783,"marketCap":60607206202},{"date":"2024-04-19","current":-48.443774,"twenty":-53.302804,"median":-27.157464,"eighty":-9.068996,"marketCap":53873072180},{"date":"2024-04-26","current":-57.196236,"twenty":-53.435518,"median":-27.450523,"eighty":-9.167423,"marketCap":63528035417},{"date":"2024-05-03","current":-59.794233,"twenty":-53.777852,"median":-27.730775,"eighty":-9.397396,"marketCap":66367730487},{"date":"2024-05-10","current":-60.546292,"twenty":-54.435313,"median":-28.113255,"eighty":-9.857114,"marketCap":67362014561},{"date":"2024-05-17","current":-58.658055,"twenty":-54.574873,"median":-28.485417,"eighty":-9.977493,"marketCap":65165427130},{"date":"2024-05-24","current":-52.700238,"twenty":-54.976338,"median":-29.07698,"eighty":-10.139927,"marketCap":58412954655},{"date":"2024-05-31","current":-51.620118,"twenty":-54.976338,"median":-29.361089,"eighty":-10.283386,"marketCap":57273983395},{"date":"2024-06-07","current":-52.565196,"twenty":-54.976338,"median":-30.241673,"eighty":-10.532117,"marketCap":58250244475},{"date":"2024-06-14","current":-56.319381,"twenty":-54.981036,"median":-31.054417,"eighty":-10.718314,"marketCap":62353269027},{"date":"2024-06-21","current":-54.227183,"twenty":-55.099632,"median":-32.881149,"eighty":-10.838576,"marketCap":59911234992},{"date":"2024-06-28","current":-54.249689,"twenty":-55.440028,"median":-33.56094,"eighty":-11.097775,"marketCap":59911234992},{"date":"2024-07-05","current":-58.463788,"twenty":-55.657871,"median":-34.005125,"eighty":-11.220642,"marketCap":64551099658},{"date":"2024-07-12","current":-59.938373,"twenty":-55.745963,"median":-34.181189,"eighty":-11.407271,"marketCap":66276432299},{"date":"2024-07-19","current":-59.716353,"twenty":-55.97848,"median":-34.545269,"eighty":-11.738708,"marketCap":66032170263},{"date":"2024-07-26","current":-57.074426,"twenty":-56.131334,"median":-34.806278,"eighty":-12.250774,"marketCap":63345287873},{"date":"2024-08-02","current":-57.621526,"twenty":-56.307104,"median":-34.994572,"eighty":-12.425719,"marketCap":63915232622},{"date":"2024-08-09","current":-60.772336,"twenty":-56.714024,"median":-35.324454,"eighty":-12.694151,"marketCap":67859465726},{"date":"2024-08-16","current":-59.654815,"twenty":-57.048523,"median":-35.648167,"eighty":-12.850581,"marketCap":66637506560},{"date":"2024-08-23","current":-63.107395,"twenty":-57.458873,"median":-35.962733,"eighty":-13.047453,"marketCap":70792167727},{"date":"2024-08-30","current":-49.12916,"twenty":-57.66299,"median":-36.345755,"eighty":-13.206187,"marketCap":69162888838},{"date":"2024-09-06","current":-49.915263,"twenty":-57.66299,"median":-36.567164,"eighty":-13.37092,"marketCap":70303384060},{"date":"2024-09-13","current":-51.145513,"twenty":-57.66299,"median":-36.671875,"eighty":-13.573848,"marketCap":71847570529},{"date":"2024-09-20","current":-49.167101,"twenty":-57.683721,"median":-36.986342,"eighty":-13.63831,"marketCap":69482554019},{"date":"2024-09-27","current":-53.462204,"twenty":-57.683721,"median":-37.445773,"eighty":-13.783867,"marketCap":76006737495},{"date":"2024-10-04","current":-58.949991,"twenty":-57.776104,"median":-37.558101,"eighty":-13.908798,"marketCap":83427996199},{"date":"2024-10-10","current":-56.643507,"twenty":-57.816343,"median":-37.60917,"eighty":-13.995484,"marketCap":79676590700},{"date":"2024-10-18","current":-54.316933,"twenty":-57.819489,"median":-37.924768,"eighty":-14.224435,"marketCap":75975160467},{"date":"2024-10-25","current":-51.747614,"twenty":-57.819489,"median":-38.255535,"eighty":-14.2894,"marketCap":72376767507},{"date":"2024-11-01","current":-40.961176,"twenty":-57.819489,"median":-38.986697,"eighty":-14.340877,"marketCap":57328942398},{"date":"2024-11-08","current":-45.608937,"twenty":-57.819489,"median":-39.308677,"eighty":-14.420988,"marketCap":63544348421},{"date":"2024-11-15","current":-44.200719,"twenty":-57.819489,"median":-39.497388,"eighty":-14.54548,"marketCap":60930246271},{"date":"2024-11-22","current":-43.988394,"twenty":-57.819489,"median":-39.586206,"eighty":-14.672188,"marketCap":60602664302},{"date":"2024-11-29","current":-45.857239,"twenty":-57.819489,"median":-39.778153,"eighty":-14.785857,"marketCap":63141424563},{"date":"2024-12-06","current":-45.071237,"twenty":-57.819489,"median":-40.220709,"eighty":-14.848685,"marketCap":61912992178},{"date":"2024-12-13","current":-44.682481,"twenty":-57.819489,"median":-40.576246,"eighty":-15.014493,"marketCap":61257828240},{"date":"2024-12-20","current":-42.241276,"twenty":-57.819489,"median":-40.934902,"eighty":-15.254477,"marketCap":57654426579},{"date":"2024-12-27","current":-42.754459,"twenty":-57.819489,"median":-40.969369,"eighty":-15.339213,"marketCap":58309590517},{"date":"2025-01-03","current":-42.534452,"twenty":-57.819489,"median":-41.085429,"eighty":-15.481309,"marketCap":58066335414},{"date":"2025-01-10","current":-40.407856,"twenty":-57.819489,"median":-41.176668,"eighty":-16.193782,"marketCap":54954176393},{"date":"2025-01-17","current":-37.851954,"twenty":-57.819489,"median":-41.179186,"eighty":-16.682563,"marketCap":51519723275},{"date":"2025-01-24","current":-38.69271,"twenty":-57.819489,"median":-41.179186,"eighty":-16.915608,"marketCap":52994055579},{"date":"2025-01-28","current":-39.34211,"twenty":-57.816343,"median":-41.177927,"eighty":-16.989137,"marketCap":54140758482},{"date":"2025-02-07","current":-43.376749,"twenty":-57.822636,"median":-41.225174,"eighty":-17.320246,"marketCap":59382828895},{"date":"2025-02-14","current":-44.895241,"twenty":-57.822636,"median":-41.439791,"eighty":-17.61594,"marketCap":61432031400},{"date":"2025-02-21","current":-49.746076,"twenty":-57.822636,"median":-41.616926,"eighty":-17.999791,"marketCap":68312418916},{"date":"2025-02-28","current":-48.414447,"twenty":-57.822636,"median":-41.739825,"eighty":-18.237812,"marketCap":66264684536},{"date":"2025-03-07","current":-47.922812,"twenty":-57.825782,"median":-42.027254,"eighty":-18.551688,"marketCap":65855137660},{"date":"2025-03-14","current":-48.79914,"twenty":-57.825782,"median":-42.125115,"eighty":-18.662738,"marketCap":67083778288},{"date":"2025-03-21","current":-48.401057,"twenty":-57.825782,"median":-42.299167,"eighty":-18.935846,"marketCap":66510412662},{"date":"2025-03-28","current":-55.188745,"twenty":-57.825782,"median":-42.496478,"eighty":-19.437399,"marketCap":75684262684},{"date":"2025-04-03","current":-812.530138,"twenty":-57.971959,"median":-42.563523,"eighty":-19.437399,"marketCap":82318922076},{"date":"2025-04-11","current":-779.078321,"twenty":-58.17521,"median":-42.754459,"eighty":-19.437399,"marketCap":78223453316},{"date":"2025-04-17","current":-769.900239,"twenty":-58.259802,"median":-42.852414,"eighty":-19.446154,"marketCap":77404359564},{"date":"2025-04-25","current":-889.264014,"twenty":-58.573908,"median":-42.97387,"eighty":-19.435927,"marketCap":89578154558},{"date":"2025-05-02","current":-896.357794,"twenty":-58.735668,"median":-42.988967,"eighty":-19.437399,"marketCap":90484649223},{"date":"2025-05-09","current":-849.575932,"twenty":-58.959846,"median":-43.1845,"eighty":-19.435927,"marketCap":86364218930},{"date":"2025-05-16","current":-820.85164,"twenty":-59.318718,"median":-43.369817,"eighty":-19.435927,"marketCap":84125961099},{"date":"2025-05-23","current":-940.361806,"twenty":-59.416193,"median":-43.416299,"eighty":-19.435927,"marketCap":96662378831},{"date":"2025-05-30","current":-989.768217,"twenty":-59.721419,"median":-43.519443,"eighty":-19.435927,"marketCap":102188299805},{"date":"2025-06-06","current":-1165.735261,"twenty":-59.85563,"median":-43.586357,"eighty":-19.435927,"marketCap":120663020674},{"date":"2025-06-13","current":-1287.14885,"twenty":-60.074121,"median":-43.654071,"eighty":-19.435927,"marketCap":133282988343},{"date":"2025-06-20","current":-1241.733329,"twenty":-60.490073,"median":-43.829003,"eighty":-19.435927,"marketCap":128328230412},{"date":"2025-06-27","current":-1232.687947,"twenty":-60.772336,"median":-43.882417,"eighty":-19.437399,"marketCap":127750175320},{"date":"2025-07-02","current":-1263.361744,"twenty":-61.083148,"median":-43.91364,"eighty":-19.437399,"marketCap":130970767976}],"updateTime":1751506209886}}}